热门资讯> 正文

PAVmed GAAP每股收益0.87美元

2026-08-14 20:02

PAVmed press release (PAVM): Q2 GAAP EPS of $0.87.
Revenue rose to $33K.
PAVmed had cash and cash equivalents of $3.8 million as of June 30, 2026, compared to $1.5 million as of December 31, 2025.

More on PAVmed

PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript
PAVmed Inc. 2026 Q1 - Results - Earnings Call Presentation
PAVmed Q2 2026 Earnings Preview
Seeking Alpha’s Quant Rating on PAVmed
Historical earnings data for PAVmed

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。